StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) stock

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Aethlon Medical profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Aethlon Medical's profit margin for the twelve months ending Mar 31, 2023 was -2094.9%. For fiscal 2023 it was -2094.9%, against -3540.9% the year before. The highest annual figure on record is -397.7% in fiscal 2013.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Mar 31, 2023-2094.9%+1446.0
FY2022Mar 31, 2022-3540.9%−2344.3
FY2021Mar 31, 2021-1196.6%−216.3
FY2020Mar 31, 2020-980.3%+1717.4
FY2019Mar 31, 2019-2697.8%+1098.1
FY2018Mar 31, 2018-3795.9%−1940.1
FY2017Mar 31, 2017-1855.8%−1306.2
FY2016Mar 31, 2016-549.6%+342.0
FY2015Mar 31, 2015-891.5%−68.9
FY2014Mar 31, 2014-822.6%−424.9
FY2013Mar 31, 2013-397.7%+198.9
FY2012Mar 31, 2012-596.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2023CQ1 2023Mar 31, 2023-429.6%+1159.7
Q4 FY2022CQ1 2022Mar 31, 2022-28858.5%−22257.3
Q3 FY2022CQ4 2021Dec 31, 2021-14755.7%−14364.7
Q2 FY2022CQ3 2021Sep 30, 2021-1521.6%−659.2
Q1 FY2022CQ2 2021Jun 30, 2021-1589.3%−1391.0
Q4 FY2021CQ1 2021Mar 31, 2021-6601.2%+286.9
Q3 FY2021CQ4 2020Dec 31, 2020-390.9%+1661.7
Q4 FY2020CQ1 2020Mar 31, 2020-862.4%−96.4
Q3 FY2020CQ4 2019Dec 31, 2019-198.2%+1564.7
Q1 FY2020CQ2 2019Jun 30, 2019-6888.1%−5264.0
Q4 FY2019CQ1 2019Mar 31, 2019-2052.6%−1470.5
Q1 FY2019CQ2 2018Jun 30, 2018-766.1%+45163.1
Q4 FY2018CQ1 2018Mar 31, 2018-1762.9%–
Q3 FY2018CQ4 2017Dec 31, 2017-1624.1%–
Q2 FY2017CQ3 2016Sep 30, 2016-582.2%–
Q1 FY2017CQ2 2016Jun 30, 2016-45929.2%–

More Aethlon Medical figures

See a number that looks wrong?